Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Yamashita Health Care Holdings's PB Ratio or its related term are showing as below:
TSE:9265'
s PB Ratio Range Over the Past 10 Years
Min: 0.44 Med: 0.66 Max: 1.09
Current: 0.93
During the past 9 years, Yamashita Health Care Holdings's highest PB Ratio was 1.09. The lowest was 0.44. And the median was 0.66.
TSE:9265's PB Ratio is ranked better than 57.66% of 111
companies
in the Medical Distribution industry
Industry Median: 0.99
vs TSE:9265: 0.93
During the past 12 months, Yamashita Health Care Holdings's average Book Value Per Share Growth Rate was 1.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.80% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Yamashita Health Care Holdings was 7.80% per year. The lowest was 4.40% per year. And the median was 5.55% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Yamashita Health Care Holdings PB Ratio Related Terms
Yamashita Health Care Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Yamashita Health Care Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's PB Ratio falls into.
Yamashita Health Care Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Yamashita Health Care Holdings (TSE:9265) has a PB Ratio of 0.92 as of Aug. 03, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Yamashita Health Care Holdings and its competitors. This is 39% above median its historical median of 0.66. Over the past decade, Yamashita Health Care Holdings' PB Ratio has ranged from 0.44 to 1.09. According to the industry distribution chart, Yamashita Health Care Holdings ranks #47 out of 111 companies in the Medical Distribution industry, placing it in the top 42.3%.
Is Yamashita Health Care Holdings' PB Ratio too high?
Yamashita Health Care Holdings' current PB Ratio of 0.92 is 39% above median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 1.09. The Medical Distribution industry median PB Ratio is 0.99. Yamashita Health Care Holdings' value of 0.92 is 7.1% below this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #47 out of 111 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Yamashita Health Care Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #47 out of 111 companies for PB Ratio. This puts Yamashita Health Care Holdings in the upper half of its industry. The industry median PB Ratio is 0.99. Yamashita Health Care Holdings' value of 0.92 is 7.1% below this benchmark. Historically, Yamashita Health Care Holdings' own PB Ratio has ranged from 0.44 to 1.09 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 0.99, Yamashita Health Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 0.99, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current PB Ratio of 0.92 is 7.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median PB Ratio is 0.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current PB Ratio is 0.92, which is 39% above median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,955.01, compared to a current price of 円3,395.00 — trading 14.9% above its estimated fair value. The current PB Ratio is 0.92, which is 39% above median its 10-year median of 0.66 and 7.1% below the Medical Distribution industry median of 0.99. Yamashita Health Care Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current PB Ratio is 0.92 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,395.00 is trading 14.9% above its estimated GF Value™ of 円2,955.01.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
PB Ratio: 0.92 (39% above median its 10-year median of 0.66)
GF Value™: 円2,955.01 vs. price of 円3,395.00 (14.9% above fair value)
Industry Position: 7.1% below the Medical Distribution median (#47 of 111)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
64GF Score
Get the complete analysis for TSE:9265
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
